Showing results (61-70 of 500) with videos related to
Sort By:
Pageof 50
Princess Takamatsu Symposia|January 1, 1988
In vivo administration of anti-CD3 monoclonal antibody can activate immune responses thus preventing malignant tumor growthR Hirsch, J D Ellenhorn, J A BluestoneTransplantation|March 15, 1996
In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cellsE S Woodle, S Hussein, J A BluestoneNature|November 19, 1987
Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytesL A Matis, R Cron, J A BluestoneJournal of Visualized Experiments : Jove|November 8, 2008
Transplantation of pancreatic islets into the kidney capsule of diabetic miceGregory L Szot, Pavel Koudria, Jeffrey A BluestoneCurrent Opinion in Organ Transplantation|July 16, 2010
Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortiaLaurence A Turka, Kathryn Wood, Jeffrey A BluestoneNature Reviews. Rheumatology|October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritisJonathan H Esensten, David Wofsy, Jeffrey A BluestoneJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated miceJ D Ellenhorn, H Schreiber, J A BluestoneThe Journal of Experimental Medicine|April 1, 1983
Antiidiotypes against anti-H-2 monoclonal antibodies. V. In vivo antiidiotype treatment induces idiotype-specific helper T cellsH Auchincloss, J A Bluestone, D H SachsInternational Reviews of Immunology|December 2, 2005
Achieving antigen-specific tolerance in diabetes: regulating specificallyWei Chen, Jeffrey A Bluestone, Kevan C HeroldCold Spring Harbor Perspectives in Medicine|February 10, 2025
Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of InsulinJeffrey A Bluestone, Kevan C Herold, Lori SusselPageof 50